SPRY Therapeutics, an AI-driven practice management platform, has raised $15 million in funding from Flourish Ventures, Together Fund, Fidelity's Eight Roads, and F-Prime Capital.
The total funding for SPRY Therapeutics now stands at $25 million since its launch in 2021.
The funding will be used to support the company's expansion across the US market.
SPRY Therapeutics provides an end-to-end patient and practice management platform for physical therapists, offering automation for billing processes and addressing patient engagement and reporting.